Search

everythinglearnresearchcommunity

for

Search:↓

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Vitex negundo may help treat PCOD, but more human studies are needed.

High-dose radioactive iodine therapy does not harm fertility in thyroidectomy patients.

Estrogen deficiency in postmenopausal women can cause skin and hair issues, but local estrogen therapies help improve vaginal health.

Biologic agents are effective for severe hidradenitis suppurativa when other treatments fail.

Combining lifestyle changes and medication is most effective for managing PCOS symptoms.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Low vitamin D3 is not linked to different levels of thyroid hormones in people with autoimmune thyroid disease.

Correct testosterone levels for age to treat prostate cancer, using low dose treatments as necessary.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Early identification of lupus through skin signs and blood tests is crucial in India.

Certain gene variations are linked to a higher risk of severe acne, suggesting a genetic influence on the condition.

PCOS is a common condition in women that can lead to infertility and other health issues, and it's diagnosed by specific criteria with various treatment options available.

Longer anogenital distance may indicate a higher chance of having polycystic ovary syndrome, and measuring this distance along with hormone levels could improve diagnosis.

Removing a testicular tumor in a dog reduced its aggressive behavior and skin problems.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

PCOS involves hormonal and metabolic issues, increasing risks for diabetes and heart disease, and requires lifestyle changes and medication for management.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

Male and female skin differ in many ways, which could lead to gender-specific skin treatments.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Smoking may contribute to hair loss in men.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Costunolide may have multiple health benefits, including promoting hair growth and protecting against cancer and diabetes, but more research is needed.

Beta-sitosterol has potential health benefits but needs more research to fully understand its effects and improve its use in treatments.